Contact us for free information or to start a free case review.
Multaq® is a prescription medication to keep patients with certain abnormal heart rhythms from needing to go to the hospital to control their arrhythmia. It is intended specifically to treat atrial fibrillation, when the heart beats irregularly, and atrial flutter, when the heart beats regularly but too fast.
The drug works to increase the length of time between episodes of abnormal heart patterns.
Some data suggest an association between Multaq® and kidney disease or kidney failure. The Institute for Safe Medicine has reported 387 cases of adverse effects since the drug was approved in July 2009. Of these, there were 15 reports of kidney failure or damage. This included four cases of acute kidney failure.
The kidneys act as filters to purify the blood and rid the body of waste products in urine. They also regulate the acid-base balance in the body and the water-salt balance.
Kidney failure can be either acute or chronic.
Acute kidney failure is the rapid loss of kidney function over the course of a few hours or days. When the kidneys lose their ability to filter impurities from the blood, there is an increase in unsafe levels of wastes, fluids and electrolytes in the body.
Acute kidney failure can cause death. It occurs most often in hospitalized patients, in particular patients who are critically sick and need to be in the intensive care unit.
Some of the symptoms of renal failure or kidney failure are:
Chronic kidney disease occurs when the function of the kidneys declines slowly over time. Often there are no signs in the beginning of the disease and the early symptoms frequently occur in other illnesses so chronic kidney disease may be difficult to differentiate from other diseases.
Some symptoms of early disease include:
These may be the only symptoms until the disease has progressed to a more serious level.
If you or someone you love has taken Multaq® and then been diagnosed with kidney failure, you might want to consult a Multaq® kidney failure attorney. You might be eligible for compensation. Contact us for an evaluation of your case.
The FDA notified healthcare professionals about new findings that link Multaq® to severe liver injuries, Jan. 14, 2011. The agency said there were two report...
Copyright © 2001 - 2012 Online Lawyer Source | Legal Marketing Site Designed by eJustice
ATTORNEY ADVERTISEMENT—Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer.